VCYT FY 2013 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena

VCYTVeracyte, Inc.

$3B

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M+88.2% YoY

Gross Profit

$9M42.4% margin

Operating Income

-$23M-105.9% margin

Net Income

-$26M-116.9% margin

EPS (Diluted)

$-6.15

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$20M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$80M

Total Liabilities

$23M

Stockholders' Equity

$56M

Cash & Equivalents

$71M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$12M	+88.2%
Gross Profit	$9M	$4M	+129.4%
Operating Income	-$23M	-$19M	-22.4%
Net Income	-$26M	-$19M	-37.2%